A new, affordable anti-malarial drug
This year, malaria will strike 200 million people. More than 600,000 of those people will die, most of them under the age of five.
A new anti-malarial drug developed by Jay Keasling’s UC Berkeley Lab could save the lives of hundreds of millions of people by making treatment more affordable. The drug is the first triumph of the nascent field of synthetic biology (which involves inserting a dozen or more genes into microbes to make them produce drugs, chemicals or biofuels that they normally would not).
Read the full story →